Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement: Gastroenterology

University of British Columbia

$41,250.00

Role of CDK10 in colorectal cancer

FY 2013-14

Summary
Colorectal cancer is the second highest cause of death from cancer in Canada. In 2012, an estimated 23,300 Canadians were diagnosed with colorectal cancer and 9,200 died of it. Most deaths from this disease are caused by resistance to treatment and/or the spread of the original disease to other parts of the body, a process called metastasis. Understanding how colorectal cancer cells resist chemotherapy and spread is therefore vital to improving treatments and survival rates for this disease. Our team has already identified several proteins that are more abundant in colorectal tumours than in normal tissue. Among them is a protein called CDK10, which is responsible for participating in cell division, and has not yet been reported as being involved in colorectal cancer. I propose to undertake a detailed study of how this protein is involved in colorectal cancer. My results could help physicians identify the colorectal tumours that are most likely to not respond to treatment and to spread to other parts of the body, leading to new therapeutic strategies.
Program
Fellowship - Priority Announcement: Gastroenterology
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
302113
Name
Weiswald Louis-Bastien
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Takeda Canada Inc. (Mississauga, Ontario)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of CDK10 in colorectal cancer
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$41,250
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Gastroenterology
Keyworddelim
Cancer Stem Cells; Cell Biology; Chemoresistance; Colorectal Cancer; Cyclin Dependent Kinases; Invasion; Metastasis; Migration; Molecular Biology; Xenografts
Abstract
Colorectal cancer is the second highest cause of death from cancer in Canada. In 2012, an estimated 23,300 Canadians were diagnosed with colorectal cancer and 9,200 died of it. Most deaths from this disease are caused by resistance to treatment and/or the spread of the original disease to other parts of the body, a process called metastasis. Understanding how colorectal cancer cells resist chemotherapy and spread is therefore vital to improving treatments and survival rates for this disease. Our team has already identified several proteins that are more abundant in colorectal tumours than in normal tissue. Among them is a protein called CDK10, which is responsible for participating in cell division, and has not yet been reported as being involved in colorectal cancer. I propose to undertake a detailed study of how this protein is involved in colorectal cancer. My results could help physicians identify the colorectal tumours that are most likely to not respond to treatment and to spread to other parts of the body, leading to new therapeutic strategies.
Competitiondate
201311
Approvedterm2
1 yr 7 mths
Pinamesdelim
Weiswald, Louis-Bastien
Approvedterm
1 an 7 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $41,250~ $0~